中华骨科杂志
中華骨科雜誌
중화골과잡지
CHINESE JOURNAL OF ORTHOPAEDICS
2012年
1期
46-51
,共6页
施培华%姜洋子%胡志军%黄悦%张剑%虞和君%邹晓晖%欧阳宏伟
施培華%薑洋子%鬍誌軍%黃悅%張劍%虞和君%鄒曉暉%歐暘宏偉
시배화%강양자%호지군%황열%장검%우화군%추효휘%구양굉위
细胞移植%软骨细胞%膝关节
細胞移植%軟骨細胞%膝關節
세포이식%연골세포%슬관절
Cell transplantation%Chondrocytes%Knee joint
目的 探讨和研究自体软骨细胞移植技术治疗膝关节软骨缺损的临床效果和临床应用的可行性.方法 2007年11月至2009年6月,共6例膝关节软骨损伤患者.男2例,女4例;年龄19~55岁,平均39.5岁;均为膝关节股骨髁关节面软骨缺损,缺损面积为3.8~11.6 cm2,平均7.3 cm2.利用自体软骨细胞移植术进行治疗:关节镜下在膝关节股骨髁间非负重区获取软骨组织0.2g,送临床细胞培养室进行软骨细胞的培养和体外扩增2~3周;第二次手术,利用骨膜缝合覆盖,生物蛋白胶封闭,将扩增的软骨细胞悬浮液移植至软骨缺损区;术后进行严格的康复训练.术后定期进行随访,术前及术后6、12个月进行Lysholm主观评分、国际膝关节文献委员会(International Knee Documentation Committee,IKDC)客观等级评定和膝关节MRI扫描.结果 6例患者均获得随访.术前Lysholm评分(63.0±8.1)分,术后6和12个月分别为(83.7±10.6)分和(86.3±10.3)分,获得明显改善;术前IKDC等级均为C或D级,术后等级逐步获得改善.术后6个月和12个月MR检查显示所有病例软骨缺损区基本得到修复,无一例出现术后感染等严重并发症.一例患者由于未能按指导完成康复锻炼,术后患侧关节疼痛症状虽有缓解,但出现粘连,活动度部分丢失.结论 自体软骨细胞移植治疗膝关节软骨缺损初步疗效基本满意;术前需严格控制适应证,术后需高度重视康复锻炼,以保证手术疗效.
目的 探討和研究自體軟骨細胞移植技術治療膝關節軟骨缺損的臨床效果和臨床應用的可行性.方法 2007年11月至2009年6月,共6例膝關節軟骨損傷患者.男2例,女4例;年齡19~55歲,平均39.5歲;均為膝關節股骨髁關節麵軟骨缺損,缺損麵積為3.8~11.6 cm2,平均7.3 cm2.利用自體軟骨細胞移植術進行治療:關節鏡下在膝關節股骨髁間非負重區穫取軟骨組織0.2g,送臨床細胞培養室進行軟骨細胞的培養和體外擴增2~3週;第二次手術,利用骨膜縫閤覆蓋,生物蛋白膠封閉,將擴增的軟骨細胞懸浮液移植至軟骨缺損區;術後進行嚴格的康複訓練.術後定期進行隨訪,術前及術後6、12箇月進行Lysholm主觀評分、國際膝關節文獻委員會(International Knee Documentation Committee,IKDC)客觀等級評定和膝關節MRI掃描.結果 6例患者均穫得隨訪.術前Lysholm評分(63.0±8.1)分,術後6和12箇月分彆為(83.7±10.6)分和(86.3±10.3)分,穫得明顯改善;術前IKDC等級均為C或D級,術後等級逐步穫得改善.術後6箇月和12箇月MR檢查顯示所有病例軟骨缺損區基本得到脩複,無一例齣現術後感染等嚴重併髮癥.一例患者由于未能按指導完成康複鍛煉,術後患側關節疼痛癥狀雖有緩解,但齣現粘連,活動度部分丟失.結論 自體軟骨細胞移植治療膝關節軟骨缺損初步療效基本滿意;術前需嚴格控製適應證,術後需高度重視康複鍛煉,以保證手術療效.
목적 탐토화연구자체연골세포이식기술치료슬관절연골결손적림상효과화림상응용적가행성.방법 2007년11월지2009년6월,공6례슬관절연골손상환자.남2례,녀4례;년령19~55세,평균39.5세;균위슬관절고골과관절면연골결손,결손면적위3.8~11.6 cm2,평균7.3 cm2.이용자체연골세포이식술진행치료:관절경하재슬관절고골과간비부중구획취연골조직0.2g,송림상세포배양실진행연골세포적배양화체외확증2~3주;제이차수술,이용골막봉합복개,생물단백효봉폐,장확증적연골세포현부액이식지연골결손구;술후진행엄격적강복훈련.술후정기진행수방,술전급술후6、12개월진행Lysholm주관평분、국제슬관절문헌위원회(International Knee Documentation Committee,IKDC)객관등급평정화슬관절MRI소묘.결과 6례환자균획득수방.술전Lysholm평분(63.0±8.1)분,술후6화12개월분별위(83.7±10.6)분화(86.3±10.3)분,획득명현개선;술전IKDC등급균위C혹D급,술후등급축보획득개선.술후6개월화12개월MR검사현시소유병례연골결손구기본득도수복,무일례출현술후감염등엄중병발증.일례환자유우미능안지도완성강복단련,술후환측관절동통증상수유완해,단출현점련,활동도부분주실.결론 자체연골세포이식치료슬관절연골결손초보료효기본만의;술전수엄격공제괄응증,술후수고도중시강복단련,이보증수술료효.
Objective To investigate and evaluate the result and the possibility of the clinical application of autologous chondrocyte implant (ACI).Methods From November 2007 to June 2009,6 cases of knee articular cartilage defect were treated with ACI,including 2 males and 4 females with an average age of 39.5 years (range,19-55).All the defects were located on the condyles of femur with a mean size of 7.3 cm2 (range,3.8-11.6).ACI comprises a two-stage procedure:chondrocytes are first harvested from the non-load bearing area of the joint,expand in vitro to acquire enough cells,and then the chondrocytes are implanted.The defect of cartilage were covered with bone membrane and fixed with sutures and fibrin albumen glue.Lysholm score system,International Knee Documentation Committee (IKDC) grading system,and MRI were used to evaluate the effect of ACI,6 and 12 months post-operatively.Results All the patients were followed up.The clinical outcomes of the 6 and 12 months follow-ups demonstrated increased of clinical scores.The MRI follow-up showed good filling of the defect with tissue having the imaging appearance of cartilage in all patients.Only one patient suffered adhesion,because she refused to finish rehabilitation exercises as our treatment advises.Conclusion As the clinical effect of ACI for knee cartilage defect is satisfied,the ACI may be a good choice for treating knee cartilage defect in future.It is very important to control the indications strictly and guarantee to finish the post-operative rehabilitation exercises.